Now available to help womenaffected by the common problem of Stress Urinary Incontinence (SUI) (http://www.defluxsui.com/
Steve Foley, Consultant Urologist at the Royal Berkshire Hospital in Reading believes bladder weakness is a much more widespread problem than the statistics suggest. He says, “My belief is that the majority of women will suffer from this condition, either because of childbirth or the menopause. It is a silent epidemic that women are really scared to talk about, but injection therapy (http://www.deflux.com/
SUI is the most common form of incontinence and occurs when there is extra pressure on the bladder, causing a leakage of urine. In clinical trials the Deflux™ procedure had a 74% success rate in the mild to moderate incontinent group and the treatment itself lasts for up to 5 years. It’s time to dust off that little black dress and start enjoying those festive parties again.
About Deflux™: Deflux™ gel is a viscous substance consisting of two components: dextranomer (Dx) microspheres and stabilised hyaluronic acid of non-animal origin (NASHA™). Deflux™ is completely safe and has been successfully used for a decade in both the treatment of SUI and in the treatment of more than 200,000 children affected with a condition known as vesicoureteral reflux. In the treatment of SUI, the dextranomer beads act as the bulking agent and have been shown to remain at the injection site for up to four years. The hyaluronic acid is the carrier agent, which disappears from the body.
For more information, images, videos or interviews with Steve Foley, please contact Cream Communications on 0845 388 9584/07715709982 or email firstname.lastname@example.orgemail@example.com